InterCure Ltd. — Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for November 2022 on November 23, 2022. The filing references Exhibit 99.1, a press release dated November 23, 2022, but the press release text is not included in the provided filing content.
Financial Metrics
The provided filing text does not include clear values for revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes Versus Prior Period
The filing text does not provide information sufficient to identify material changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items. These matters may be addressed in the referenced Exhibit 99.1, which is not included.
Important Facts to Verify
- Obtain and review Exhibit 99.1, the November 23, 2022 press release.
- Verify whether the press release contains financial results, operational updates, guidance, or transaction-related disclosures.
- Confirm any reported revenue, profitability, cash flow, debt, liquidity, and cannabis-market operating metrics directly from the complete exhibit.